Clinical trial
Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic…
NCT00177853 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00177853 |
|---|---|
| Title | Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer |
| Official title | A Phase I Study of Celecoxib, Irinotecan and Concurrent Radiotherapy in the Preoperative Treatment of Pancreatic Cancer |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Pharmacia and Upjohn Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | celecoxib, irinotecan, concurrent radiotherapy |
| Enrollment | 23 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Jul 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: